Variant Bio

People-Driven Therapeutics

[Variant Bio @VariantBio]

Right on the heels of our press release announcing a deal with Novo Nordisk, we're thrilled to see this NY Times coverage of the partnership and Variant Bio's ethics-first approach to drug discovery: https://t.co/ehNLqmvPch

[Variant Bio @VariantBio]

Findings from our recent papers in @ScienceMagazine and @NatureComms include health risks and drug-target leads the largest databases miss: https://t.co/rCdSEwQXcH

[Alexander G. Ioannidis @alexGioannidis]

With co-author @stephanecastel of @VariantBio in front of our cover of @ScienceMagazine at ASHG @GeneticsSociety in Montreal. Come to their booth and get a free copy! Missing my co-senior author @KeoluFox.

[Josh Wolfe @wolfejosh]

Lux family co @VariantBio

we created + funded this company to find outlier people in outlier parts of the world with outlier traits...

to develop new drugs for all of the rest of us.

[Variant Bio @VariantBio]

Out today on the cover of @ScienceMagazine: work led by @KeoluFox (UCSD) and Alexander Ioannidis (Stanford) with @VariantBio. Polynesians experienced founder effects 10x stronger than Finland’s, with big implications for drug discovery and clinical care: https://t.co/9dnY6OX7Eo

[Variant Bio @VariantBio]

Dr. Sarah LeBaron von Baeyer from Variant Bio presenting with our brilliant partner Dr. June Fabian from the University of the Witwatersrand on how we have together implemented the community-driven distribution of financial benefits for genomics research projects in South Africa.

[Variant Bio @VariantBio]

Variant Bio leverages AI-powered Inference platform in an expanded collaboration with @Boehringer: https://t.co/SNU2UZy9Hp

[Variant Bio @VariantBio]

Thrilled to announce our latest drug development collaboration! We are now expanding our existing partnership with @Boehringer into cardiovascular disease for a total potential deal value exceeding $250 mm: https://t.co/uwbQxIYtif

[Variant Bio @VariantBio]

Check out this upcoming webinar by our very own @OliviaG_PhD! Register here 👉 https://t.co/adkLk443Pb

[Variant Bio @VariantBio]

Variant Bio’s Senior Director of Ethics & Engagement discusses lessons learned from educational and health initiatives in Rwanda: https://t.co/uRqfvBHLdh

[Variant Bio @VariantBio]

We recently wrapped up recruitment for a genomic research study in Tahiti in partnership with Novo Nordisk and GHICL: https://t.co/rBQPBz3O8F

[Variant Bio @VariantBio]

We are thrilled to announce our latest paper published with the Faroe Genome (FarGen) project and the University of Copenhagen: https://t.co/hvxJXiw5AP

[Metabolon, Inc. @Metabolon]

Join our webinar with Dr. Olivia Gray (@VariantBio) tomorrow!

Learn how multiomics revealed mechanisms affecting creatinine-based eGFR estimates in African ancestry populations.

📅 27 May
🕒 11 am EDT | 5 pm CEST

🔗https://t.co/mQVsUg0tOS

[Metabolon, Inc. @Metabolon]

Can genetics bias kidney disease biomarkers?

In our next webinar, Dr. Olivia Gray (@VariantBio) will show how multiomics revealed mechanisms affecting creatinine-based eGFR estimates in African ancestry populations.

📅 27 May
🕑 11 am EDT | 5 pm CEST

🔗 https://t.co/mQVsUg0tOS

[Variant Bio @VariantBio]

Variant Bio recently launched a new study focused on diabetes in Bangladesh in partnership with Novo Nordisk and icddr,b: https://t.co/UdmqGsPdW1

[Variant Bio @VariantBio]

In honor of International Nurses Day -- celebrated on the anniversary of Florence Nightingale's birth -- the team @VariantBio owes a huge THANK YOU to nurses around the world (including in Tahiti, pictured here) who make our research studies possible. Cheers to nurses everywhere!

[Variant Bio @VariantBio]

Dr. Moira Gunn from @biotechnation interviewed @AndrewFarnum and Dr. Sarah LeBaron von Baeyer from @VariantBio for NPR this week on how AI, ethics, and diverse data can help us develop better drugs and diagnostics: https://t.co/nEzBug4Wqo

[Andrew Farnum @AndrewFarnum]

Alpha in biotech comes from looking where no one else is. At @VariantBio, we’ve built a proprietary engine to uncover human genetic evidence that the rest of the industry is missing. I had a great deep dive into the ethics and science of our approach on @biotechnation today.

[Andrew Farnum @AndrewFarnum]

Thank you for hosting a great conversation on our work @VariantBio, Dr. Moira Gunn! @biotechnation https://t.co/XLcAInWKKc

[Variant Bio @VariantBio]

“In the era of precision medicine, [a]dding more data from the global north may offer only incremental insight, whereas African data has the potential for genuinely novel discovery. It is a meaningful step toward inclusion and equity”: https://t.co/Pp1glZE0hI

[Variant Bio @VariantBio]

In honor of National Doctors' Day today, we would like to thank all the doctors we have worked with in partner communities around the world, as well as the doctors who are committed to helping patients with the new medicines we are developing @VariantBio.